Low operative mortality with implantation of a continuous-flow left ventricular assist device and impact of concurrent cardiac procedures

Circulation

Volumn 120, Issue SUPPL. 1, 2009, Pages

  Pal, Jay D ^a   Klodell, Charles T ^b   John, Ranjit ^c   Pagani, Francis D ^d   Rogers, Joseph G ^a   Farrar, David J ^e   Milano, Carmelo A ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^c UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^d UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^e THORATEC CORPORATION   (United States)

Author keywords

Left ventricular assist device; Mechanical circulatory support; Transplantation

Indexed keywords

ADULT; ARTICLE; FEMALE; HEART ASSIST DEVICE; HEART LEFT VENTRICLE; HUMAN; MAJOR CLINICAL STUDY; MALE; MITRAL VALVE REPLACEMENT; PATENT FORAMEN OVALE; PRIORITY JOURNAL; SURGICAL MORTALITY; SURVIVAL; TRICUSPID VALVE REPLACEMENT; AGED; CAUSE OF DEATH; HEART TRANSPLANTATION; HEART VALVE; MIDDLE AGED; MORTALITY;

ADULT; AGED; CAUSE OF DEATH; FEMALE; FORAMEN OVALE, PATENT; HEART TRANSPLANTATION; HEART VALVES; HEART-ASSIST DEVICES; HUMANS; MALE; MIDDLE AGED;

EID: 70349787006     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.108.844274     Document Type: Article

References (18)

1. 1. Miller LW, Pagani FD, Russell SD, John R, Boyle AJ, Aaronson KD, Conte JV, Naka Y, Mancini D, Delgado RM, MacGillivray TE, Farrar DJ, Frazier OH. Use of a continuous-flow device in patients awaiting heart transplantation. N Engl J Med. 2007;357:885-896. (Pubitemid 47347322)
2. Pagani FD, Miller LW, Russell SD, Aaronson KD, John R, Boyle AJ, Conte JV, Bogaev RC, MacGillivray TE, Naka Y, Mancini D, Massey HT, Chen L, Klodell CT, Aranda JM, Moazami N, Ewald GA, Farrar DJ, Frazier OH; HeartMate II Investigators. Extended mechanical circulatory support with a continuous-flow rotary left ventricular assist device. J Am. Coll Cardiol. 2009;54:312-321.
3. 3. Delgado R, Bergheim. M. HeartMate II left ventricular assist device: a new device for advanced heart failure. Exp Rev Med Devices. 2005;2: 529-532. (Pubitemid 41447650)
4. 4. Frazier OH, Delgado RM III, Kar B, Patel V, Gregoric ID, Myers TJ. First clinical use of the redesigned HeartMate II left ventricular assist system in the United States: a case report. Tex Heart Inst J. 2004;31: 157-159. (Pubitemid 38747887)
5. 5. Frazier OH, Gemmato C, Myers TJ, Gregoric ID, Radovancevic B, Loyalka P, Kar B. Initial clinical experience with the HeartMate II axial-flow left ventricular assist device. Tex Heart Inst J. 2007;34: 275-281. (Pubitemid 350057567)
6. Feldman CM, Silver MA, Sobieski MA, Slaughter MS. Management of aortic insufficiency with, continuous flow left ventricular assist devices: bioprosthetic valve replacement. J Heart Lung Transplant. 2006;25: 1410-1412.
7. 7. Bryant AS, Holman WL, Nanda NC, Vengala S, Blood MS, Pamboukian SV, Kirklin JK. Native aortic valve insufficiency in patients with left ventricular assist devices. Ann Thorac Surg. 2006;81:e6-e8. (Pubitemid 43120584)
8. 8. Rao V, Slater JP, Edwards NM, Naka Y, Oz MC. Surgical management of valvular disease in patients requiring left ventricular assist device support. Ann Thorac Surg. 2001;71:1448-1453. (Pubitemid 32452523)
9. 9. Fukamachi K, McCarthy PM, Smedira NG, Vargo RL, Starling RC, Young JB. Preoperative risk factors for right ventricular failure after implantable left ventricular assist device insertion. Ann. Thorac Surg. 1999;68:2181-2184. (Pubitemid 30027846)
10. Nakatani S, Thomas JD, Savage RM, Vargo RL, Smedira NG, McCarthy PM. Prediction of right ventricular dysfunction after left ventricular assist device implantation. Circulation. 1996;94: II-216-II-221.
11. 11. Holman WL, Bourge RC, Fan. P, Kirklin JK, Pacifico AD, Nanda NC. Influence of longer term left ventricular assist device support on valvular regurgitation. ASAIO J. 1994;40:M454-M459. (Pubitemid 24364245)
12. John R. Current axial-flow devices: the HeartMate II and Jarvik 2000 left ventricular assist devices. Semin Thorac Cardiovasc Surg. 2008;20: 264-272.
13. Unpublished Data for the Society of Thoracic Surgeons National Cardiac Database, Available at: ww.sts.org/sections/stsnationaldatabase. Accessed. November 2008.
14. John R, Kamdar F, Liao K, Colvin-Adams M, Boyle A, Joyce L. Improved survival and decreasing incidence of adverse events with the HeartMate II left ventricular assist device as bridge-to-transplant therapy. Ann Thorac Surg. 2008;86:1227-1234.
15. 15. Lietz K, Long JW, Kfoury AG, Slaughter MS, Silver MA, Milano CA, Rogers JG, Naka Y, Mancini D, Miller LW. Outcomes of left ventricular assist device implantation as destination therapy in the post-REMATCH era: implications for patient selection. Circulation. 2007;116:497-505. (Pubitemid 47450258)
16. 16. Frazier OH, Rose EA, Oz MC, Dembitsky W, McCarthy P, Radovancevic B, Poirier VL, Dasse KA. Multicenter clinical evaluation of the HeartMate vented electric left ventricular assist system, in patients awaiting heart transplantation. J Thorac Cardiovasc Surg. 2001;122: 1186-1195. (Pubitemid 33590445)
17. Hernandez AF, Shea AM, Milano CA, Rogers JG, Hammill BG, O'Connor CM, Schulman KA, Peterson ED, Curtis LH. Long-term outcomes and costs of ventricular assist devices among medicare beneficiaries. JAMA. 2008;300:2398-2406.
18. 18. Holman WL, Bourge RC, Fan P, Kirklin JK, Pacifico AD, Nanda NC. Influence of left ventricular assist on valvular regurgitation. Circulation. 1993;88:II-309-II-318. (Pubitemid 23324579)